Subutex (buprenorphine) is a prescription medication that is taken by mouth. It comes in the form of a sublingual tablet that is placed under the tongue to dissolve.
After taking Subutex, individuals should wait at least 10 to 15 minutes after the tablet has completely dissolved before eating or drinking.
It can take up to 10 minutes for Subutex tablets to fully dissolve. Talking, eating, or drinking during this time is not recommended.
Learn more about the benefits of taking Subutex
Why Do You Need To Wait To Eat After Taking Subutex?
Eating directly after taking Subutex could affect its absorption into the bloodstream. Essentially, this could make it less effective.
Unlike many prescription drugs, Subutex is not meant to be swallowed. It is put under the tongue, where it may dissolve and be absorbed into the bloodstream through the mouth.
What Happens If You Eat Too Soon After Taking Subutex
Doses of Subutex need to be fully absorbed in order to have the desired effect. If someone eats or drinks too soon after taking Subutex, this could cause it to not work as well.
Because Subutex is prescribed for opioid dependence, this means it’s possible a person could begin experiencing symptoms of opioid withdrawal if the Subutex doesn’t absorb properly.
This could cause:
- nausea
- opioid cravings
- headache
- muscle aches
- chills or sweating
- diarrhea
Serious side effects can occur after taking Subutex. If you’re experiencing cravings or other withdrawal symptoms after taking Subutex, contact your doctor for further guidance.
Learn More About Subutex Treatment For Opioid Addiction
If you have questions about Subutex or how it can be used to treat opioid addiction, one of our specialists may be able to provide the answers you’re looking for.
For more information about Subutex treatment options near you, call our helpline today.
Addiction Resource aims to provide only the most current, accurate information in regards to addiction and addiction treatment, which means we only reference the most credible sources available.
These include peer-reviewed journals, government entities and academic institutions, and leaders in addiction healthcare and advocacy. Learn more about how we safeguard our content by viewing our editorial policy.
- Substance Abuse and Mental Health Services Administration (SAMHSA) — Buprenorphine
https://www.samhsa.gov/medication-assisted-treatment/medications-counseling-related-conditions/buprenorphine - U.S. Food & Drug Administration (FDA) — SUBUTEX (buprenorphine sublingual tablets)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020732s018lbl.pdf - U.S. National Library of Medicine: MedlinePlus — Buprenorphine Sublingual and Buccal (opioid dependence)
https://medlineplus.gov/druginfo/meds/a605002.html
